Impax Pharmaceuticals Announces Extension of RYTARY FDA Review Date To January 9, 2015

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and ...